TheEdgeResearch
Home / Stocks / MMNFF

MedMen Enterprises Inc. (MMNFF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +9900.00%
Market Cap
$138,320
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.40
52-Wk Range
1.0E-4-0.036
CEO
Melony Valleau CPA
Country
US
Currency
USD

MedMen Enterprises Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Culver City, CA, US. The stock last traded at $0.00, up 9900.00% on the session, giving a market capitalisation of $138,320. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -117.6%. Its beta of 1.40 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-6.05
Gross margin
49.5%
Operating margin
-43.5%
Net margin
-117.6%
Return on equity
Debt / equity
2.61
Current ratio
0.49
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
428
IPO date
2018-05-30
Headquarters
Culver City, CA, US
About MedMen Enterprises Inc.

MedMen Enterprises Inc., along with its associated entities, operates as a cannabis enterprise throughout the United States. The company manages the entire process for both recreational and medicinal cannabis, from cultivation and manufacturing to distribution and direct retail sales. Its products are sold under the specific brand names MedMen Red and LuxLyte. As of December 25, 2021, its retail footprint included 29 stores spread across California, Florida, Nevada, Illinois, Arizona, Massachusetts, and New York. The primary corporate offices for MedMen Enterprises Inc. are situated in Culver City, California.

Comparable companies

MedMen Enterprises Inc. is most often compared with the following Healthcare names:

ALEAFAPTCFEDNEFENDPMRVTPOTNPREDPVTTFQTXBSNDD
More research on MMNFF
MMNFF technical analysis MMNFF TheEdge Score Compare against peers
Open full interactive analysis & DCF →